SCHOTT Continues Gains in U.S. Market, Invests for Future Organic Growth
SCHOTT, the international technology group and inventor of specialty glass, maintained strong growth in the United States amid global challenges in fiscal year 2021-22.
Pharmaceutical Industry News
Mobius Therapeutics™ Granted New US Patent for Injected Ophthalmic Mitomycin-C
Mobius Therapeutics™, LLC, a St. Louis-based perioperative ophthalmic pharmaceutical company, has been issued US Patent Injection Apparatus and Method of Use.